Repository logo
 
Loading...
Thumbnail Image
Publication

Cutaneous manifestations associated with SARS CoV-2: an emerging topic in a pandemic era

Use this identifier to reference this record.

Advisor(s)

Abstract(s)

A 70-year-old man was admitted to our COVID-19 ward with thoracalgia, productive mucus cough, fatigue and erythematous–violaceous macules on the inner side of feet and interdigital regions. The patient was started on oxygen and dexamethasone. On the day of discharge, he maintained the skin changes despite the resolution of COVID-19 symptoms. A 57-year-old woman initially presented with diffuse urticarial rash on the cervical and chest region. Oral cetirizine was started, and pruritus improved. Thirty days after the discharge, the patient maintained the rash, but without pruritus. A 49-year old man was admitted with thoracalgia, shortness of breath, dry cough and urticarial rash on the cervical and chest region. The patient was treated with cetirizine. The pruritus improved, and 5 days after discharge, the urticarial areas completely disappeared

Description

Keywords

Cutaneous manifestations associated with SARS CoVID-2 SARS-COV-2 rash COVID-19 cetirizine. Madeira Island Região Autónoma da Madeira Portugal

Citation

Luís H, Barros C, André D, et al. BMJ Case Rep 2021;14:e244763. doi:10.1136/bcr-2021- 244763

Research Projects

Organizational Units

Journal Issue

Publisher

BMJ Publishing Group

CC License

Altmetrics